Myfortic

Manufacturer: 

          Novartis Pharma

Contents:  

          Mycophenolate Na

Indication: 

          Listed in Dosage.

Contraindication: 

          Pregnancy, lactation. Rare hereditary deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), including Kelley-Seegmiller or Lesch-Nyhan syndrome.

Dosage:

          Adult: PO Prophylaxis of acute renal graft rejection As mycophenolate mofetil (MMF): 1 g twice daily starting w/in 72 hr of transplantation. Max: 2 g/day. As mycophenolic acid: 720 mg twice daily. Prophylaxis of cardiac graft rejection As MMF: 1.5 g twice daily starting w/in 5 days after transplantation. IV Prophylaxis of acute renal graft rejection As MMF: 1 g twice daily starting w/in 24 hr after transplantation for up to 14 days, then convert to oral therapy.Prophylaxis of hepatic transplant rejection As MMF: 1 g twice daily for 1st 4 days ( max: 4 days) following transplantation, then convert to PO at 1.5 g twice daily. Prophylaxis of cardiac graft rejection As MMF: 1.5 g twice daily starting w/in 5 days after transplantation for up to 14 days, then convert to PO.

Class:

        Immunosuppressants

Presentation/Packing: 

       Myfortic 180 mg x 12 blisters x 10's

       Myfortic 360 mg x 12 blisters x 10's

Price

        Contact to have special price

Detail information: 

            MyPhuocPharmacy - (08) 62581003.